Earnings releaseEnglish
OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ose Immunotherapeutics
- Filed
- 30/04/2026, 07:30
- Document type
- Earnings release
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118920_20260430